Cboe UK GBp
AstraZeneca PLC (AZNL.XC)
10,758.00
+162.00
+(1.53%)
At close: May 2 at 4:29:58 PM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
13,088,000
11,861,000
10,345,000
9,808,000
5,963,000
Investing Cash Flow
-6,820,000
-7,980,000
-4,064,000
-2,960,000
-11,058,000
Financing Cash Flow
-8,731,000
-3,996,000
-6,567,000
-6,823,000
3,649,000
End Cash Position
5,229,000
5,429,000
5,637,000
5,983,000
6,038,000
Capital Expenditure
-3,950,000
-4,586,000
-3,778,000
-2,571,000
-2,200,000
Issuance of Capital Stock
-527,000
-43,000
33,000
29,000
29,000
Issuance of Debt
1,516,000
6,492,000
3,816,000
--
12,929,000
Repayment of Debt
-4,649,000
-4,652,000
-4,942,000
-1,271,000
-4,759,000
Free Cash Flow
9,138,000
7,275,000
6,567,000
7,237,000
3,763,000
12/31/2021 - 1/30/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade